Several studies have demonstrated ongoing oxidative stress in cystic fibros
is (CF). With the complexity of the antioxidant network, measurement of ind
ividual antioxidants does not necessarily assess how they work in combinati
on. One measure that has been proposed as a gauge of total plasma antioxida
nt capacity is the Trolox-equivalent antioxidant capacity (TEAC) of plasma.
We decided to look at plasma TEAC levels in children with CF, and relate t
his measure to their nutritional status, lung function, and blood measureme
nts of several known antioxidants. We hypothesized that values in general w
ould be lower than healthy control values, especially during acute pulmonar
y exacerbations. Twenty-nine children were evaluated, five of whom were dur
ing an acute pulmonary exacerbation. Height and weight, expiratory spiromet
ry, and lung volumes were assessed, as were serum concentrations of vitamin
s A and E, uric acid, albumin, and lymphocyte glutathione (GSH) concentrati
ons.
TEAC values for nonhospitalized patients (1.40 +/- 0.20 mmol/L) were not di
fferent from laboratory control values (1.35 +/- 0.11 mmol/L), but greater
than values for hospitalized patients (1.09 +/- 0.17 mmol/L). TEAC correlat
ed with anthropometric values (height: r = 0.39, P < 0.03; weight: r = 0.50
, P < 0.01; body mass index: r = 0.47, P < 0.01), and pulmonary function (f
orced expiratory volume in 1 sec: r = 0.43, P < 0.02; residual volume/total
lung capacity: r = -0.42, P < 0.03), but not with age. Univariate correlat
ion with blood measurements demonstrated a significant correlation of TEAC
with uric acid (r = 0.49, P < 0.02), but not with albumin, vitamins A or E,
or lymphocyte GSH. Multiple regression analysis demonstrated a correlation
between TEAC and uric acid, albumin, and lymphocyte GSH in the non-hospita
lized group (r(2) = 0.38, P < 0.03).
We conclude that TEAC appears to represent a mixed antioxidant response, ra
ther than response to a single antioxidant. While being responsive to oxida
tive stress, the mechanism of the response may differ between clinical situ
ations, such that the clinical significance of changes in plasma TEAC remai
ns to be defined. Pediatr Pulmonol. 2000; 29:81-87, (C) 2000 Wiley-Liss, In
c.